Valhalla, N.Y.-based Westchester Medical Center Health Network has opened Westchester Medical Center Specialty Pharmacy to expand access to coordinated pharmacy services for patients with complex, chronic and rare conditions. The in-network specialty pharmacy integrates physicians, pharmacists and patients to support…

Morgantown, W.Va.-based West Virginia University Health System has agreed to pay $4.2 million and enter a three-year compliance agreement with the Drug Enforcement Administration to resolve allegations it violated multiple provisions of the Controlled Substances Act across dozens of registered…

Rejections of initial brand-name prescription attempts increased from 24.3% in 2018 to 40.7% in 2024, according to a July 9 JAMA study. Researchers from Baltimore-based Johns Hopkins Bloomberg School of Public Health and the American Enterprise Institute led the study.…

The FDA has approved Sanofi’s subcutaneous Sarclisa Escena in combination with standard-of-care regimens for patients with multiple myeloma across all existing indications of the intravenous formulation, making it the first anticancer treatment administered through an on-body injector. Sarclisa Escena is…

For decades, the friction between a prescription and a patient was accepted as part of the process. Now, pharmacy leaders are closing that gap with AI because “to wait one moment longer is untenable.” Pharmacy has become one of healthcare’s…

A new CDC analysis is challenging assumptions about where pharmacy access in the U.S. is worst — and the answer isn’t rural America. Researchers from the Minnesota Department of Health and University of Minnesota College of Pharmacy mapped pharmacy access…

The FDA has classified a recall of more than 2.5 million bottles of prescription prednisolone acetate eye drops as Class II after the product was found to contain a foreign substance. The recall affects 2,530,182 bottles of Prednisolone Acetate Ophthalmic…

Chemotherapy drugs cisplatin, carboplatin, oxaliplatin and ifosfamide are in shortage again, but five health systems are managing without the treatment delays and drug rationing that defined 2023.  Shortages of the drugs have been straining hospital supply chains since June, with…

Net spending on medicines in the U.S. climbed $58 billion, or 10.6%, from 2024 to 2025, reaching $606 billion, according to an April 28 IQVIA Institute report. Here are five things to know from the report:

The FDA has classified three drug recalls as Class II actions in enforcement reports released July 8, affecting injectable medications distributed in the U.S. Here are the recalled drugs: